Valentina-Alexandra Badaluta

Mrs. Valentina-Alexandra Badaluta

Department of Botany & Microbiology, University of Bucharest, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Valentina-Alexandra BadalutaValentina-Alexandra Badaluta
Valentina-Alexandra Badaluta
Carmen CurutiuCarmen Curutiu
Carmen Curutiu
Lia-Mara DituLia-Mara Ditu
Lia-Mara Ditu
Alina Maria HolbanAlina Maria Holban
Alina Maria Holban
Veronica LazarVeronica Lazar
Veronica Lazar
Wound infections caused by opportunistic bacteria promote persistent infection and represent the main cause of delayed healing. Probiotics are acknowledged for their beneficial effects on the human body and could be utilized in the management of various diseases. They also possess the capacity to accelerate wound healing, due to their remarkable anti-pathogenic, antibiofilm, and immunomodulatory effects. Oral and topical probiotic formulations have shown promising openings in the field of dermatology, and there are various in vitro and in vivo models focusing on their healing mechanisms. Wound dressings embedded with prebiotics and probiotics are now prime candidates for designing wound healing therapeutic approaches to combat infections and to promote the healing process. The aim of this review is to conduct an extensive scientific literature review regarding the efficacy of oral and topical probiotics in wound management, as well as the potential of wound dressing embedding pre- and probiotics in stimulating the wound healing process.

Verified
Journal Article
Open access
PDF file
Gabriela PetcuGabriela Petcu
Gabriela Petcu
Elena Madalina CiobanuElena Madalina Ciobanu
Elena Madalina Ciobanu
GPGabriela Paun
Gabriela Paun
ENElena Neagu
Elena Neagu
ABAdriana Baran
Adriana Baran
Viorica ParvulescuViorica Parvulescu
Viorica Parvulescu
Ag nanoparticles (AgNPs) were biosynthesized using sage (Salvia officinalis L.) extract. The obtained nanoparticles were supported on SBA-15 mesoporous silica (S), before and after immobilization of 10% TiO2 (Degussa-P25, STp; commercial rutile, STr; and silica synthesized from Ti butoxide, STb). The formation of AgNPs was confirmed by X-ray diffraction. The plasmon resonance effect, evidenced by UV-Vis spectra, was preserved after immobilization only for the sample supported on STb. The immobilization and dispersion properties of AgNPs on supports were evidenced by TEM microscopy, energy-dispersive X-rays, dynamic light scattering, photoluminescence and FT-IR spectroscopy. The antioxidant activity of the supported samples significantly exceeded that of the sage extract or AgNPs. Antimicrobial tests were carried out, in conditions of darkness and white light, on Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Candida albicans. Higher antimicrobial activity was evident for SAg and STbAg samples. White light increased antibacterial activity in the case of Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa). In the first case, antibacterial activity increased for both supported and unsupported AgNPs, while in the second one, the activity increased only for SAg and STbAg samples. The proposed antibacterial mechanism shows the effect of AgNPs and Ag+ ions on bacteria in dark and light conditions.

8 November 2023 in Materials
Verified
Journal Article
Open access
PDF file
MLMarcut Lavinia
Marcut Lavinia
AMAurel George Mohan
Aurel George Mohan
ICIuliana Corneschi
Iuliana Corneschi
EGElena Grosu
Elena Grosu
Gheorghe PaltaneaGheorghe Paltanea
Gheorghe Paltanea
Lia-Mara DituLia-Mara Ditu
Lia-Mara Ditu
An endotracheal tube (ETT) is a greatly appreciated medical device at the global level with widespread application in the treatment of respiratory diseases, such as bronchitis and asthma, and in general anesthesia, to provide narcotic gases. Since an important quantitative request for cuffed ETTs was recorded during the COVID-19 pandemic, concerns about infection have risen. The plasticized polyvinyl chloride (PVC) material used to manufacture ETTs favors the attachment of microorganisms from the human biological environment and the migration of plasticizer from the polymer that feeds the microorganisms and promotes the growth of biofilms. This leads to developing infections, which means additional suffering, discomfort for patients, and increased hospital costs. In this work, we propose to modify the surfaces of some samples taken from commercial ETTs in order to develop their hydrophobic character using surface fluorination by a plasma treatment in SF6 discharge and magnetron sputtering physical evaporation from the PTFE target. Samples with surfaces thus modified were subsequently tested using XPS, ATR-FTIR, CA, SEM + EDAX, profilometry, density, Shore A hardness, TGA-DSC, and biological antimicrobial and biocompatibility properties. The obtained results demonstrate a successful increase in the hydrophobic character of the plasticized PVC samples and biocompatibility properties.

16 June 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
Diana Antonia CosteaDiana Antonia Costea
Diana Antonia Costea
Valentina-Alexandra BadalutaValentina-Alexandra Badaluta
Valentina-Alexandra Badaluta
IZIoana Zachia-Zlatea
Ioana Zachia-Zlatea
Alina Maria HolbanAlina Maria Holban
Alina Maria Holban
Lia-Mara DituLia-Mara Ditu
Lia-Mara Ditu
Veronica LazarVeronica Lazar
Veronica Lazar
Biofilms are structured communities of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) matrix, whose development significantly enhances microbial resistance to antibiotics, disinfectants, and host immune defenses, posing major challenges in clinical, industrial, and environmental settings. Compared with planktonic cells, biofilm-associated microorganisms can exhibit up to 10- to 1000-fold increased tolerance to antimicrobial agents, contributing to the persistence of biofilm-associated infections (BAIs). These infections remain difficult to eradicate due to reduced penetration, altered metabolic states, and the presence of dormant or persister cells. Anti-biofilm strategies can be broadly classified into physical approaches (e.g., ultrasound, mechanical stress, and light-based approaches) that target biofilm structure; chemical and enzymatic methods (e.g., EPS-degrading enzymes) that destabilize the matrix; and biological and molecular strategies (e.g., quorum-sensing (QS) inhibitors, anti-virulence agents, bacteriophages, phage-derived antimicrobial molecules, antimicrobial peptides, and natural bioactive compounds) that modulate biofilm development and integrity by targeting regulatory pathways and matrix stability through distinct mechanisms of action. Natural compounds, including lactoferrin, lactoferrin-derived peptides, and probiotic and postbiotic fractions of lactic acid bacteria (LAB), as well as plant-derived metabolites, have shown promising anti-biofilm effects, with efficacy often enhanced through complementary or potentially synergistic interactions. However, despite these advancements, clinical translation remains limited. For example, BAIs account for approximately 80% of chronic infections, with high recurrence rates and therapeutic failure reported in device-associated infections and chronic wounds. These limitations highlight the need for clinically translatable, multimodal approaches that integrate structural biofilm disruption, antimicrobial targeting, and host response modulation to design more effective and sustainable anti-biofilm strategies.

12 August 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Valentina-Alexandra BadalutaValentina-Alexandra Badaluta
Valentina-Alexandra Badaluta
AIAdrian Ionascu
Adrian Ionascu
Lia-Mara DituLia-Mara Ditu
Lia-Mara Ditu
CCCarmen Curutiu
Carmen Curutiu
AHAlina-Maria Holban
Alina-Maria Holban
VLVeronica Lazar
Veronica Lazar
Background: Natural bioactive compounds such as terpenoids and phenolic acids have emerged as promising agents in dermatological research due to their proven antioxidant, antimicrobial and anti-inflammatory properties. Hidradenitis Suppurativa (HS), a chronic inflammatory condition, presents a therapeutic challenge that could benefit from innovative approaches harnessing these natural compounds.Objective: The present study aimed to evaluate the antimicrobial and immunomodulatory effects of phytoconstituent agents (FCs) including Gallic Acid (GA), α–Terpineol (αT) and Nerolidol (N), both individually and in combinations. The potential of these compounds to enhance immune regulation and inhibit biofilm development in HS-related pathogen was explored through in vitro investigations, emphasizing their therapeutic potential in managing HS-related infections and inflammation.Methods: Phytocompounds (FCs) (GA, αT and N) were obtained by solubilization in dimethyl sulfoxide (DMSO) at an initial concentration of 10 mg/mL and tested against standard and clinical strains of HS-associated pathogens. Additionally, Lactic Acid Bacterial (LAB) strains isolated from normal microbiota, dental plaque and lactic fermented foods were assessed for their antimicrobial, anti-biofilm and immunomodulatory effect, using both qualitative and quantitative assays. The immunomodulatory properties were analyzed using macrophages differentiated from THP-1 human monocytic cells. Cytokine modulation was measured via Enzyme-Linked Immunosorbent Assay (ELISA).Results: The combination of α-terpineol and nerolidol demonstrated potent antimicrobial activity and markedly inhibiting biofilm development, particularly against Gram-positive bacterial strains. A significant modulation of the inflammatory response, including enhanced IL-10 induction, was observed when Lactobacillus paracasei was combined with either nerolidol or α-terpineol.Conclusions: These findings underscore the potential of natural bioactive compounds and their combinations as promising candidates for further investigation in managing skin infections and inflammation-related disorders, including HS. Future studies are essential to optimize formulations, evaluate compound stability, cytotoxicity and skin penetration and establish efficacy in vivo, paving the way for the development of well-tolerated and effective topical formulations.

15 May 2025 in Journal of Microbes in Health and Disease
Verified
Journal Article
Open access
PDF file
Veronica LazarVeronica Lazar
Veronica Lazar
Valentina-Alexandra BadalutaValentina-Alexandra Badaluta
Valentina-Alexandra Badaluta
RARoxana M. Apetrei
Roxana M. Apetrei
Lia-Mara DituLia-Mara Ditu
Lia-Mara Ditu
Staphylococcus aureus (S. aureus) is one of the most common pathogens and likely an ancient commensal component of human microbiota. From a global perspective, S. aureus ranks among the most frequent pathogens affecting humans and animals, with significant morbidity and mortality rates. It is a commensal bacterial species present in approximately 30% of individuals, residing on the skin and mucosal surfaces. However, it is also the etiological agent of a wide range of infections, including pyogenic skin infections, superficial infections, deep tissue, and organ infections. These can progress to systemic conditions such as bacteremia and severe sepsis. Additionally, S. aureus produces enterotoxins that can lead to food poisoning. This highly versatile opportunistic pathogen is implicated in device-related infections associated with biofilm formation, as well as toxin-mediated conditions such as scalded skin syndrome and toxic shock syndrome (TSS), which are mediated by exfoliatins and TSST-1 (toxic shock syndrome toxin-1), respectively. S. aureus possesses a wide array of virulence factors, including toxins with superantigen properties that can trigger a “cytokine storm” and hyperinflammation. The incidence of S. aureus infections has risen over the past two decades, including both community-acquired infections—such as skin and soft tissue infections caused by virulent, β-lactam-resistant strains—and hospital-acquired infections, including infective endocarditis and prosthetic device-related infections. This increase in incidence has also been marked by the rise of antibiotic-resistant strains, particularly methicillin-resistant S. aureus (MRSA) and, more recently, vancomycin-resistant clones. In this review, we aim to highlight the distinctive characteristics of S. aureus, a ubiquitous bacterial species and opportunistic pathogen that straddles the line between its commensal role and its aggressive profile as an etiological agent of numerous infections. This dual nature is due to its genetic adaptability, which enables resistance to various environmental presure and antimicrobial agents. The tolerance of biofilm-encased cells to antibiotics, its extensive repertoire of virulence factors, and its remarkable fitness. The increasing prevalence of immunocompromised individuals has further contributed to its pathogenic potential. Finally, we summarize the primary alternative and complementary anti-infective strategies for addressing S. aureus infections.